High levels of metals in body raise ALS risk, affect patient survival
People with higher levels of certain metals in their blood and urine are more likely to develop amyotrophic lateral…
Articles by Marisa Wexler, MS
Brain-computer interface allows man with ALS to communicate
A brain-computer interface allowed Casey Harrell, a 45-year-old man with amyotrophic lateral sclerosis (ALS) whose disease had made it…
Deficits in protein-metal complexes may underlie SOD1-ALS: Study
Changes in how the SOD1 protein associates with metal molecules seem to be key for how mutations affecting this protein…
PrimeC normalizes iron biomarkers in Phase 2b ALS trial
One year of treatment with the experimental oral therapy PrimeC led to improved iron accumulation in people with amyotrophic…
Clene submits new CNM-Au8 data to FDA ahead of upcoming meeting
Clene will soon meet with the U.S. Food and Drug Administration (FDA) to discuss the potential pathway to accelerated…
Mutation in IGFBP7 gene linked to rare phenomenon of ALS reversal
A mutation in the IGFBP7 gene is associated with a very rare phenomenon in which people with amyotrophic lateral…
ILB may slow ALS progression, per data from small clinical trial
Treatment with a high dose of ILB, an experimental injection therapy being developed by Tikomed, was well tolerated…
In ALS, certain spinal cord nerves die faster than others: Study
In amyotrophic lateral sclerosis (ALS), nerve cells in the spinal cord responsible for inhibiting motor neurons are lost in…
CNM-Au8 shows survival benefit after 3.5 years: Analysis
After up to 3.5 years on the experimental oral treatment CNM-Au8, the chances of survival for people with…
$2M grant supports new clinical trial of MyoRegulator for ALS
The U.S. Department of Defense (DoD) has awarded more than $2 million to help Pathmaker Neurosystems conduct a…